SMA fatigue mystery: scientists probe exercise limits in 34 patients
NCT ID NCT05518773
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at why people with spinal muscular atrophy (SMA) often feel very tired and have trouble exercising. Researchers tested 34 ambulatory SMA patients who were already on standard treatments (risdiplam or nusinersen) for at least six months. Participants did an exercise test on a special bike to measure peak oxygen uptake, and also had a simple, non-invasive muscle oxygen measurement. The goal was to understand the role of mitochondria in fatigue and exercise intolerance, which could guide future therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this study finds clear links between SMA, mitochondrial function, and fatigue, it could point toward new ways to manage tiredness and improve exercise ability in SMA patients.
- What could go wrong
- This is a small, single-visit observational study with only 34 participants. It does not test any new treatment, so any insights are preliminary and need confirmation in larger, longer studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can gene therapy help babies with SMA reach milestones? a Real-World review
- School transitions put to the test for children with a rare muscle disease
- Horseback therapy may boost movement and breathing in kids with Muscle-Weakening disease
- Newborn screening study aims to catch rare diseases at birth
- Gene therapy trial aims to halt Muscle-Wasting disease
- Higher dose of spinraza tested in SMA patients who already tried risdiplam